Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
GDUFA III Talks Completed; Fees will Fund Inspection, Complex Generic Improvements
02 Sep 2021
•
By
Derrick Gingery
GDUFA III was the last of three FDA human drug and biologic user fee renewal agreements to be completed. • Source: Alamy
More from User Fees
More from Pathways & Standards